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Abstract: Background: Xenogeneic soft tissue substitutes are currently being investigated as an
alternative to subepithelial connective tissue grafts (CTG) with the intention to avoid postoperative
morbidity associated with autologous grafting. The aim of the present study was to volumetrically
evaluate the e↵ectiveness and mid-long-term stability of a porcine-derived collagen matrix (PDCM)
(Mucoderm®, Botiss gmbh, Berlin, Germany) in increasing soft tissue volume at the buccal aspect of
molar implant sites. Methods: Periodontally healthy non-smoking patients with a single tooth gap in
the molar area were selected for a prospective case series. All sites had a bucco-oral bone dimension
of at least 8 mm and demonstrated a horizontal alveolar defect. A wide diameter implant was placed
under the elevated buccal flap and a PDCM was applied. The primary outcome was the linear
increase in buccal soft tissue profile (BSP) within a well-defined area of interest. This was performed
with designated software (SMOP; Swissmeda AG, Zurich, Switzerland) on the basis of superimposed
digitalized study casts taken before surgery (T0), immediately after surgery (T1), at three months (T2),
one year (T3) and three years (T4). Secondary outcomes were alveolar process deficiency and clinical
parameters. Results: Fourteen out of 15 treated patients attended the three-year re-assessment (four
females; mean age 51.4 years). Mean linear increase in BSP at T1 was 1.53 mm (p = 0.001). The PDCM
showed substantial resorption at T2 (1.02 mm or 66.7%) (p = 0.001). Thereafter, a 0.66 mm volume
gain was observed (p = 0.030), possibly due to the installation of a permanent crown displacing the
soft tissues to the buccal aspect. This resulted in a linear increase in BSP of 1.17 mm (76.5%) at T4.
Alveolar process deficiency significantly reduced over time (p = 0.004). However, 50% of patients
still demonstrated a slight (6/14) or obvious (1/14) alveolar process deficiency at study termination.
Implants demonstrated healthy clinical conditions. Conclusions: The PDCM demonstrated marked
resorption during the early stages of healing. Due to the matrix thickening the tissues, and the
permanent crown displacing the tissues, 76.5% of the initial increase in BSP could be maintained
over a three-year period. Half of the patients failed to show perfect soft tissue convexity at the
buccal aspect.
Keywords: collagen matrix; soft tissue substitute; soft tissue augmentation; dental implant;
single tooth
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1. Introduction
The success of dental implant treatment is no longer solely defined by successful osseointegration
and implant function over time. Patients have become more demanding with respect to aesthetic
aspects. As a result, soft tissue augmentation procedures are often performed at implant sites to
improve the aesthetic outcome [1]. This seems also to be justified from a biological point of view, since
significant buccal bone remodeling and thus loss of buccal convexity are inevitable following tooth
extraction [2]. The latter may hamper a favorable aesthetic result as a horizontal volume loss at the
buccal aspect causes a shadow in the corresponding region [3]. Therefore, soft tissue augmentation can
be performed to partially compensate for missing volume at the buccal aspect of implants. This can only
be considered if the remaining bone volume allows complete embedding of the implant shoulder [4–7].
The critical threshold value of mucosal thickness from an aesthetic point of view appears to be 2 mm.
In vitro and in vivo data suggest that when the mucosal thickness exceeds 2 mm, the human eye is
incapable of detecting any discoloration of the mucosa due to underlying restorative materials [8,9].
From a biological point of view, however, there is still a lack of scientific evidence as to whether
thicker peri-implant soft tissues limit the incidence of peri-implant disease [10]. According to a recent
systematic review, the use of a subepithelial connective tissue graft (CTG) for gain of mucosal thickness
resulted in significantly less marginal bone loss over time but no significant improvement in bleeding
on probing, pocket depth and plaque index [11].
The use of CTG harvested from the palate is considered the gold standard for soft tissue
augmentation around dental implants [6,7]. Long-term data are available showing 85% relative
horizontal stability at the buccal aspect after five years [12]. However, its greatest demerit is the
harvesting procedure at the donor site, which may lead to complications such as palatal bleeding,
swelling, infection or necrosis [6,13,14]. In addition, anatomical and individual limitations exist,
leading to a variable quantity and quality of tissue that can be harvested [15]. Therefore, current
research focuses on alternative devices to replace autogenous tissue.
A newly developed porcine-derived acellular collagen matrix (PDCM) (Mucoderm®, Botiss gmbh,
Berlin, Germany) composed of non-crosslinked natural type I and type III collagen was introduced and
found to be successful for gingival augmentation and root coverage [16–23]. More recently, the matrix
was proposed as an autogenous graft substitute for increasing soft tissue thickness under closed
healing conditions. The ability to increase soft tissue thickness with good histological integration
was demonstrated in preclinical studies [24–29]. To the best of our knowledge, two clinical studies
have been performed with this matrix, yet both demonstrate important limitations [23,30]. First,
there was no proper baseline registration in these studies. Second, measurements were performed
using transmucosal probing by an endodontic instrument or anesthesia needle with a silicone stop.
Both may be considered quite inaccurate when small tissue changes are to be identified. Finally, the
follow-up of these studies ranged between 6 and 12 months.
The primary objective of this three-year prospective study was to volumetrically evaluate the
e↵ectiveness of this PDCM in increasing buccal soft tissue volumes at single implants in the molar area.
2. Material and Methods
2.1. Patient Selection
Patients in need of a single implant restoration in the molar area were enrolled in a private practice
and at the University Dental Clinic of Brussels University (VUB) between 2015 and 2017 to be involved
in a prospective case series. Patients were recruited according to inclusion and exclusion criteria.
Inclusion criteria were as follows:
• Minimum 18 years old
• Good oral hygiene (Full-mouth plaque score  25%) [31]
•
J. Clin. Med. 2020, 9, 1568 3 of 14
• Adjacent tooth present at both sides of the defect
• Failing tooth at least 3 months prior to enrolment removed
• Seibert Class I defect at the single tooth gap as clinically assessed (buccal concavity with a normal
apicocoronal ridge height) [32]
• Su cient amount of keratinized mucosa available at the single tooth gap
• Bucco-oral bone dimension of at least 8 mm as assessed on cone beam computed tomography
(CBCT) at the central and crestal aspect of the single tooth gap to ensure complete embedding of a
wide diameter implant by bone
• Signed informed consent
Exclusion criteria were as follows:
• Systemic diseases
• Smokers
• Untreated caries lesions
• (History of) periodontal disease
• Horizontal bone augmentation required at implant placement
The PROCESS statement for preferred reporting of case series in surgery was adopted [33,34].
The study was approved by the Ethical Committee of the Brussels University Hospital (UZ Brussel;
B.U.N. 143201524133) and performed in accordance with the ethical standards of the Declaration of
Helsinki in 1975, as revised in 2013.
2.2. Surgical and Prosthetic Procedures
Patients were instructed to take systemic antibiotics (Amoxicillin 2 g) and anti-inflammatory
medication (Ibuprofen 600 mg) 1 h pre-operatively. Just prior to the treatment, patients rinsed with a
0.12% chlorhexidine solution (Perio-aid® Intensive Care, Dent-Aid Benelux, Houten, The Netherlands).
Following local anesthesia (Septanest special®, noradrenaline 1/100.000, Septodont, Saint Maur
des Fossés, France), a crestal incision at the single tooth gap and sulcular incisions at both adjacent teeth
were made. Then a full-thickness mucoperiosteal flap was raised. A NobelActive® Wide Platform
implant (Nobel Biocare AB, Göteborg, Sweden) was placed in an ideal three-dimensional position [35].
Just prior to surgery, a PDCM (Mucoderm®, Botiss gmbh, Berlin, Germany) was soaked in sterile
saline. After implant installation, it was adapted to themesiodistal dimension of the defect by trimming
with a scalpel. In apico-coronal dimensions, the PDCM was 7 mm. In case of advanced horizontal
defects, the 1.5 mm thick matrix was folded in half and secured with resorbable sutures (Serafit®
6/0, Serag-Wiessner, Naila, Germany). As such, a thickness of 3 mm could be reached. Following
superficial incision to release muscle tension, the PDCM was positioned under the elevated buccal
flap and fixed with one or two sutures (Seralon® 5/0, Serag-Wiessner, Naila, Germany) at the occlusal
aspect of the buccal flap (Figure 1).
A healing abutment was connected onto the implant prior to tension-free primary wound closure.
Patients were instructed to continue systemic antibiotics (Amoxicillin 1 g, twice/day for 4 days) and
to take anti-inflammatory medication when deemed necessary by the patient. Patients rinsed with a
0.12% chlorhexidine solution twice daily for 2 weeks. Then, sutures were removed.
Three months following surgery, permanent crowns were installed. All restorations were
screw-retained monolithic Zirconia crowns.
J. Clin. Med. 2020, 9, 1568 4 of 14
J. Clin. Med. 2020, 9, x FOR PEER REVIEW 3 of 14 

• Adjacent tooth present at both sides of the defect 
• Failing tooth at least 3 months prior to enrolment removed 
• Seibert Class I defect at the single tooth gap as clinically assessed (buccal concavity 
with a normal apicocoronal ridge height) [32] 
• Sufficient amount of keratinized mucosa available at the single tooth gap 
• Bucco-oral bone dimension of at least 8 mm as assessed on cone beam computed 
tomography (CBCT) at the central and crestal aspect of the single tooth gap to ensure 
complete embedding of a wide diameter implant by bone 
• Signed informed consent 
Exclusion criteria were as follows: 
• Systemic diseases 
• Smokers 
• Untreated caries lesions 
• (History of) periodontal disease 
• Horizontal bone augmentation required at implant placement 
The PROCESS statement for preferred reporting of case series in surgery was adopted [33,34]. 
The study was approved by the Ethical Committee of the Brussels University Hospital (UZ Brussel; 
B.U.N. 143201524133) and performed in accordance with the ethical standards of the Declaration of 
Helsinki in 1975, as revised in 2013. 
2.2. Surgical and Prosthetic Procedures 
Patients were instructed to take systemic antibiotics (Amoxicillin 2 g) and anti-inflammatory 
medication (Ibuprofen 600 mg) 1 h pre-operatively. Just prior to the treatment, patients rinsed with a 
0.12% chlorhexidine solution (Perio-aid® Intensive Care, Dent-Aid Benelux, Houten, The 
Netherlands). 
Following local anesthesia (Septanest special®, noradrenaline 1/100.000, Septodont, Saint Maur 
des Fossés, France), a crestal incision at the single tooth gap and sulcular incisions at both adjacent 
teeth were made. Then a full-thickness mucoperiosteal flap was raised. A NobelActive® Wide 
Platform implant (Nobel Biocare AB, Göteborg, Sweden) was placed in an ideal three-dimensional 
position [35]. 
Just prior to surgery, a PDCM (Mucoderm®, Botiss gmbh, Berlin, Germany) was soaked in sterile 
saline. After implant installation, it was adapted to the mesiodistal dimension of the defect by 
trimming with a scalpel. In apico-coronal dimensions, the PDCM was 7 mm. In case of advanced 
horizontal defects, the 1.5 mm thick matrix was folded in half and secured with resorbable sutures 
(Serafit® 6/0, Serag-Wiessner, Naila, Germany). As such, a thickness of 3 mm could be reached. 
Following superficial incision to release muscle tension, the PDCM was positioned under the elevated 
buccal flap and fixed with one or two sutures (Seralon® 5/0, Serag-Wiessner, Naila, Germany) at the 
occlusal aspect of the buccal flap (Figure 1). 
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Figure 1. (A) Intra-operative view: the porcine-derived collagen matrix (PDCM) (Mucoderm®,
Botiss gmbh, Berlin, Germany) was trimmed to the desired shape and size and then positioned under
the elevated buccal flap. (B) In case of advanced horizontal defects, the PDCM was folded in half and
secured with resorbable sutures.
2.3. Volumetric Analysis
Alginate impressions (CavexColorChange, Haarlem, TheNetherlands)were taken at the following
time points in each patient: T0 (pre-op), T1 (immediately post-op), T2 (3 months), T3 (1 year) and
T4 (3 years). Cast models (Sheraplaster Hartgips White, SHERA Werksto↵-Technologie, Lemförde,
Germany) were fabricatedwithin 2 h and optically scannedwith a scanner (LS3 scanner, KaVo, Biberach,
Germany) creating digital surface models in STL (Surface Tessellation Language) format. The obtained
STL files were imported into a digital imaging software program developed to compare surfaces and
analyze volumetric changes (SMOP, Swissmeda AG, Zurich, Switzerland).
A study-relevant area of interest (AOI) at the buccal aspect was selected for each augmented site
at T4 with the permanent crown in situ. The AOI reached from 0.5 mm below the mucosal margin
to 4 mm more apical, determined by a ruler in the software. In the mesiodistal dimension, the AOI
reached from the mesial to the distal line angle of the implant crown (Figure 2). The set AOIs varied
between patients due to individual anatomic di↵erences but remained fixed in each patient and site
over time.
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Figure 2. The digital surface model at T0 (yellow) and the digital surface model at T4 (blue) were
superimposed. The area of interest (black box), located at the buccal aspect of the grafted area,
was determined on the T4 model with the definitive crown in situ.
fi j
3). ean dimensional change (m 3) within the AOI for each patient at T1, 2, 3 and T4 was
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calculated by the software. As the size of the AOI (mm2) di↵ered among patients, the mean volume
change per area was converted to a mean linear change in buccal soft tissue profile (BSP) in mm to
enable a direct comparison between patients:
Dd [mm] =
Dvol
h
mm3
i
Darea [mm2]
(1)
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2.5.5. Plaque and Bleeding on Probing
Plaque and bleeding on probing were recorded at 1 year and 3 years of function. Measurements
were performed at four sites (mesio-buccal, buccal, disto-buccal and oral) around the implant. Each site
was given a score of 0 or 1 according to the absence or presence of plaque or bleeding on probing,
respectively. Both parameters were expressed as a percentage.
2.6. Statistical Analysis
All the surgical procedures as well as the clinical measurements and follow-up (implant
survival, periapical radiographs, probing depth, plaque and bleeding on probing) were performed
by two experienced surgeons (TDB and JC). The measurements for the volumetric analysis, alveolar
process deficiency and marginal bone loss were done by an independent examiner (CE). Duplicate
measurements were performed for alveolar process deficiency and marginal bone loss by a second
independent examiner (EB) on the basis of 20 randomly selected cases (File S1).
Statistical analysis was accomplished in SPSS Statistics 26 (SPSS inc., Chicago, IL, USA) with the
patient as the unit of analysis. Descriptive statistics comprised mean values and standard deviations
for continuous variables (age, linear change in BSP, marginal bone loss, probing depth, plaque and
bleeding on probing) and frequency distributions for categorical variables (gender, jaw, implant length,
alveolar process deficiency).
Given a normal distribution of linear changes in BSP, a possible time e↵ect was evaluated using
repeated measures ANOVA. In case a significant time e↵ect was found, the paired samples t-test was
used to compare time points pairwise with a Bonferroni adjustment for multiple comparisons.
Changes in alveolar process deficiency between T0 and T4 were evaluated by means of the
Wilcoxon signed-rank test. Kappa statistics were calculated to assess inter-examiner reliability on
alveolar process deficiency.
Since violation against a normal distribution was found for marginal bone loss, probing depth,
plaque and bleeding on probing, the Wilcoxon signed-rank test was used to compare the 3-year and
1-year results. Inter-examiner reliability on marginal bone loss was assessed using the intraclass
correlation coe cient (ICC).
The level of significance was set at 0.05.
3. Results
3.1. Patients
The study population consisted of 15 patients (10 males, 5 females) with a mean age of 51.4 years
(range: 31–79 years). Four wide diameter (5.5 mm) implants were placed in the maxilla, eleven in the
mandible. Implant length was 7 mm in 2 patients, 8.5 mm in 6 patients and 10 mm in 7 patients. Of the
15 patients, one dropped out at one-year follow-up due to unwillingness to return despite several
contact attempts.
3.2. Volumetric Analysis
Linear changes in BSP are summarized in Table 1 and Figure 4. A significant time e↵ect was
observed (p < 0.001). The greatest linear increase in BSP amounted to 1.53 mm and was observed
immediately post-surgery (T1) (p = 0.001). An obvious shrinkage of 1.02 mmwas found at T2 (p = 0.001).
BSP remained stable between T2 and T3 (p = 0.820) and between T3 and T4 (p = 0.163). However,
between T2 and T4 a significant linear increase in BSP of 0.66 mm was observed (p = 0.030). The final
linear increase in BSP amounted to 1.17 mm. The latter was significantly di↵erent from 0 (p < 0.001),
indicating that the PDCM was e↵ective in increasing BSP. At three years, a relative horizontal stability
of 76.5% was observed since 1.17 mm of the immediate gain of 1.53 mm could be maintained.
J. Clin. Med. 2020, 9, 1568 7 of 14
Table 1. Linear increase in buccal soft tissue profile (BSP) at the di↵erent time points.
Mean (SD) 95% CI p-Value
T1 1.53 (0.66) (1.01; 2.05) 0.001 *
T2 0.51 (0.43) (0.17; 0.84) 0.001 *
T3 0.89 (0.45) (0.64; 1.14) 0.820
T4 1.17 (0.52) (0.89; 1.45) 0.163
* Significantly di↵erent to preceding time point.J. Clin. Med. 2020, 9, x FOR PEER REVIEW 7 of 14 
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interval (CI) at the di↵erent time points.
3.3. Alveolar Process Deficiency
Kappa for inter-examiner reliability on alveolar process deficiency was 0.729 (p < 0.001)
corresponding to a substantial agreement between duplicate measurements.
The results are illustrated in Figure 5. Given the inclusion of Seibert Class I defects at baseline,
all patients demonstrated slight-to-obvious alveolar process deficiency prior to surgery. As a result of
soft tissue aug entation by means of the PDCM, alveolar process deficiency significantly reduced over
time (p = 0.004). Interestingly, 50% of patients still demonstrated slight (6/14) or obvious (1/14) alveolar
process deficiency at study termination. Figure 6 demonstrates three di↵erent clinical cases at T4.
J. Clin. Med. 2020, 9, x FOR PEER REVIEW 7 of 14 

 
Figure 4. Line chart with the mean linear increase in buccal soft tissue profile (BSP) and 95% 
confidence interval (CI) at the different time points. 
3.3. Alveolar Process Deficiency 
Kapp  for inter-examiner reliability on alveolar process deficiency was 0.729 (p < 0.001) 
corresponding to a substantial agreement between duplicate measurements. 
The results are illustrated in Figure 5. Given the inclusion of Seibert Class I defects at baseline, 
all patients demonstrated slight-to-obvious alveolar process deficiency prior to surgery. As a result 
of soft tissue augmentation by means of the PDCM, alveolar process deficiency significantly reduced 
over time (p = 0.004). Interestingly, 50% of patients still demonstrated slight (6/14) or obvious (1/14) 
alveolar process deficiency at study termination. Figure 6 demonstrates three different clinical cases 
at T4. 
 
Figure 5. Bar chart on alveolar process deficiency at T0 (pre-op, n = 15), T1 (immediately post-op, n = 
15), T2 (3 months, n = 14), T3 (1 year, n = 11) and T4 (3 years, n = 14). 
ϱ
ϭ ϭ ϭ
ϭϬ
ϯ
ϰ
ϲ ϲ
ϭϮ
ϵ
ϰ
ϳ
dϬ dϭ dϮ dϯ dϰ
Alveolar process deficiency
Obvious Slight No
Figure 5. Bar chart on alveolar process deficiency at T0 (pre-op, n = 15), T1 (immediately post-op,
n = 15), T2 (3 months, n = 14), T3 (1 year, n = 11) and T4 (3 years, n = 14).
J. Clin. Med. 2020, 9, 1568 8 of 14
J. Clin. Med. 2020, 9, x FOR PEER REVIEW 8 of 14 

(A) (B) (C) 
Figure 6. Clinical cases at T4 demonstrating (A) no alveolar process deficiency; (B) slight alveolar 
process deficiency; (C) obvious alveolar process deficiency. 
3.4. Clinical Parameters 
Over the three-year period, all implants survived. With regard to complications, an abscess 
occurred in two patients at the augmented site during the early stages of healing. These patients took 
systemic antibiotics for another four days and the symptoms disappeared. There were no other 
complications over the three-year period. 
Clinical parameters are shown in Table 2. Implants showed low plaque levels, probing depth 
and bleeding on probing with no significant difference between the one- and three-year data, 
suggesting healthy clinical conditions until study termination. The ICC on duplicate marginal bone 
loss registrations amounted to 0.98 (pȹ< 0.001), suggesting excellent inter-examiner reliability. 
Marginal bone loss was not observed. In fact, slight bone gain with borderline significance was found 
between T3 and T4 (p = 0.086). Figure 7 shows periapical radiographs at different time points yielding 
stable peri-implant conditions. 
Table 2. Clinical parameters. 
Parameter T3 T4 p-value * 
Marginal bone loss (mm) § 
ƺ0.06 (0.85) 
0.05 (ƺ0.10; 0.25) 
ƺ0.13 (0.70) 
ƺ0.30 (ƺ0.40; 0.05) 
0.086 
Probing depth (mm) 
2.5 (0.5) 
2.3 (2.3; 3.3) 
2.8 (0.9) 
3.0 (2.3; 3.3) 
0.195 
Plaque score (%) 
11 (17) 
0 (0; 25) 
20 (21) 
25 (0; 50) 
0.480 
Bleeding on probing (%) 
18 (20) 
25 (0; 25) 
39 (23) 
25 (25; 50) 
0.057 
Bold: Mean (SD); Italic: Median (IQ range); § Baseline: implant installation. Negative value indicates 
bone gain. * Comparison between 1- and 3-year data using the Wilcoxon signed-rank test. 
  
Figure 6. Clinical cases at T4 demonstrating (A) no alveolar process deficiency; (B) slight alveolar
process deficiency; (C) obvious alveolar process deficiency.
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Over the three-year period, all implants s rvived. With regard to complications, an abscess
occurred in two patients at the augmented site during the early stages of healing. These patients
took systemic antibiotics for another four days and the symptoms disappeared. There were no other
complications over the three-year period.
Clinical parameters are shown in Table 2. Implants showed low plaque levels, probing depth
and bleeding on probing with no significant di↵erence between the one- and three-year data,
suggesting healthy clinical conditions until study termi ation. The ICC on duplicate marginal
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Marginal bone loss was not observed. In fact, slight bone gain with bord li e significance was found
between T3 and T4 (p = 0.086). Figure 7 shows periapical radiographs at di↵erent time points yielding
stable peri-implant conditions.
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4. Discussion
The primary objective of the present study was to volumetrically evaluate the e↵ectiveness and
stability of a newly developed PDCM (Mucoderm®, Botiss gmbh, Berlin, Germany) in increasing
soft tissue volume at the buccal aspect of molar implant sites. Xenogeneic soft tissue substitutes are
currently investigated as alternatives to CTG in order to avoid patient morbidity and complications
related to autologous grafting. The results of the present study may add relevant information to the
existing knowledge as with three-year data, this study provides the longest follow-up on PDCM for
augmenting soft tissue volume.
Soft tissue augmentation is indicated to increase soft tissue volume around dental implants mainly
from an aesthetic point of view [1]. As it concerned a newly developed collagen matrix without any
evidence in e↵ectiveness and integration at the time this study was initiated, the molar area was chosen.
The matrix was not standardized in mesiodistal dimension and thickness. Its dimensions were adapted
to the individual site, aiming for a complete fill of the buccal defect. Looking at the results of alveolar
process deficiency at T1, this could be achieved in 12 out of 15 patients.
The measurement of soft tissue changes over time is di cult when small alterations occur. In the
past, di↵erent methods have been used including predominantly transmucosal probing, as well as
ultrasonic devices [12,37–39] and 2D measurements on CBCT slices [40,41]. The main disadvantage
of these methods is that the data only pertain to one specific point of the implant site. More recently,
volumetric assessment based on superimposed digital surface models has been developed where
the volumetric data pertain to a well-defined area of interest [42]. The volumetric analysis has been
shown to be accurate and reproducible [43]. Moreover, the technique is non-invasive and there is no
radiation exposure.
The results of the present study demonstrate that the PDCM is e↵ective in increasing buccal
soft tissue volume, pointing to a final linear increase in BSP of 1.17 mm. This corresponds to a
relative horizontal stability of 76.5% over the three-year period. These findings are in line with two
recent clinical studies evaluating the e↵ectiveness of soft tissue volume augmentation by the same
PDCM [23,30]. In the study of Zafiropolous et al., 2016 a mean increase in buccal soft tissue thickness
of 1.06 mm was measured after six months. The study of Stefanini et al., 2020 reported a mean increase
of 1.20 mm after one year. In contrast to the present study, however, both studies used less accurate
registration methods based on transmucosal probing with an endodontic instrument or anesthesia
needle. In addition, proper baseline registrations are lacking as no measurements were performed
immediately post-operative to register the immediate gain.
Apart from the final outcome, the soft tissue changes within the three-year period are important
to evaluate. Interestingly, 1.02 mm of the initial volume gain of 1.53 mm got lost after three months
(T2), indicating substantial resorption of the matrix. Between T2 and T4, 0.66 mm of that loss was
regained. This could imply that the PDCM further remodeled after three months, hereby facilitating
connective tissue ingrowth and volume gain. On the other hand, Zafiropoulos et al., 2016 used the
same non-cross-linked PDCM and described no remnants after six months which is indicative of fast
biodegradation. A more plausible explanation for the tissue gain between T2 and T4 is the installation
of the permanent crown, displacing the soft tissues to the buccal aspect. In this regard, it would be
meaningful to conduct an RCT comparing the PDCM with no soft tissue augmentation. Such a study
would enable an assessment of the true contribution of the matrix to the increase in BSP.
Several clinical studies have been published on alternative collagen matrices for peri-implant
soft tissue augmentation. Four studies were found on Mucograft® (Geistlich Pharma AG, Wolhusen,
Switzerland) assessing soft tissue thickness changes by transmucosal probing [44–46] or ultrasound [39].
The mean increase in buccal soft tissue thickness in these studies ranged from 0.70 mm to 1.16 mm
after 3 to 12 months of follow-up. One prospective study was found on OsteoBiol Derma Standard®
(Tecnoss, Giaveno, Italy) using the same volumetric measurement method as described in the present
study [47]. An initial tissue gain of 1.57 mm was seen two weeks post-augmentation. Of this initial
gain, 0.77 mm remained after 24 months pointing to a relative horizontal stability of 49%. Four RCTs
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from the same research group investigated soft tissue augmentation using Fibro-Gide® (Geistlich
Pharma AG, Wolhusen, Switzerland) [48–51]. Transmucosal probing revealed an initial gain of 1.7 mm
with 35% shrinkage after three months and a horizontal stability of 41% three years after crown
insertion. Volumetric analysis revealed an initial linear increase in soft tissue thickness of 1.16 mm.
After three months, a significant shrinkage of 34%was found. After insertion of the final reconstruction,
stable mucosal thickness, or even a slight gain, was observed up to three years. These findings suggest
that most resorption takes place in the first three months after augmentation as a result of integration
and maturation of the grafting material. Furthermore, the presence of a reconstruction appears to
positively a↵ect soft tissue stability. Interestingly, this was also observed in the present study using
another PDCM. Altogether, it seems that substantial resorption may be expected during the early
stages of healing for all collagen matrices that have been clinically evaluated so far.
Linear increase in BSP may demonstrate clinical e↵ectiveness of a PDCM in thickening the
peri-implant mucosa, but this may not necessarily imply that the treatment objective has been reached.
The ultimate endpoint in this context is perfect soft tissue convexity at the buccal aspect. In this regard,
alveolar process deficiencymay be considered an important outcome parameter. A significant reduction
in alveolar process deficiency between baseline and three-year follow-up was observed. However,
half of the patients still demonstrated slight (6/14) or obvious (1/14) alveolar process deficiency after
three years, hereby not reaching the treatment objective. Given this and the high initial resorption rate
of collagen matrices, clinicians may want to overcompensate by applying a thicker matrix.
It should be mentioned that mainly short implants were placed in this study due to anatomical
restrictions in the posterior segment of the maxilla (sinus floor) and mandible (alveolar nerve). A wide
bone condensing implant with variable-thread design (NobelActive®Wide Platform) was used for this
purpose. It can be concluded that this implant type rendered healthy peri-implant conditions in the
mid-long-term with even a slight bone gain over time. However, these results should be interpreted
with some caution since no standardized intra-oral radiographs were taken. These show an overall
error of about 0.5 mm when assessing marginal bone level [52], which may explain our results of
bone gain.
When interpreting the results of the present study, several limitations should be taken into
consideration. First, this is not a randomized controlled study and therefore caution should be taken
when comparing the outcome to alternative techniques. In future studies, a comparison with CTG
and even with no soft tissue augmentation would be meaningful. Second, a limited number of
patients was treated in this study. A limited sample size makes it impossible to detect small changes.
Third, conventional impressions are prone to some degree of distortion due to possible volumetric
changes of the impression material over time and expansion of the dental stone. In addition, plaster is
susceptible to chipping or breakage [53–55]. Intra-oral scans are preferred to produce digital surface
models. However, at the time this study was initiated, an intra-oral scanner was not available in
our center. Alginate impressions were poured in dental stone within 2 h to counteract these possible
dimensional alterations. Finally, patient-reported outcome measures are lacking. Su ciently powered
long-term RCTs need to be conducted in the future to evaluate the e↵ectiveness, volume stability and
patient-reported outcomes of this collagen matrix as an alternative to CTG in the aesthetic zone.
5. Conclusions
The PDCM demonstrated marked resorption during the early stages of healing. Due to the matrix
thickening the tissues, and the permanent crown displacing the tissues, 76.5% of the initial increase in
BSP could be maintained over a three-year period. Although alveolar process deficiency significantly
reduced over time, half of the patients failed to show perfect soft tissue convexity at the buccal aspect
after three years.
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